Status:
UNKNOWN
Qatar PREgnancy Covid-19 OUtcome Study
Lead Sponsor:
Hamad Medical Corporation
Conditions:
COVID-19
Pregnant Women
Eligibility:
FEMALE
18-50 years
Brief Summary
The in-utero exposure of acute viral infection in some instances is proven to have short- and long-term neonatal effects during the postnatal and childhood period and the Zika virus, measles, mumps, a...
Detailed Description
The coronavirus disease 2019 or 'COVID-19' is a respiratory tract infection caused by the novel coronavirus strain initially (1). On 12th March 2020, the World Health Organization declared it as a 'pa...
Eligibility Criteria
Inclusion
- Pregnant woman with suspected or confirmed SARS-CoV-2 infection
- Postpartum women who delivered during the last six weeks and
- Neonate(s) of women included in the registry
Exclusion
- Nonpregnant woman with suspected or confirmed SARS-CoV-2 infection
- Postpartum women who delivered after six weeks
Key Trial Info
Start Date :
May 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2023
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT05349279
Start Date
May 25 2021
End Date
April 15 2023
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Wellness and Research Center
Doha, Qatar